Depression and Its Relationship to Physical Activity and Obesity by Barrett, Ann
DEPRESSION AND ITS RELATIONSHIP TO PHYSICAL ACTIVITY AND OBESITY
A Thesis 
Presented in Fulfillment of the Requirements for
Graduation with Distinction from the School of Allied 
Medical Professions of The Ohio State University
By
Ann Barrett
The Ohio State University
School of Allied Medical Professions
Medical Dietetics Program
2012
Honors Thesis Examination Committee:
Dr. Christopher A. Taylor, Advisor
Dr. Kay N. Wolf
Dr. Jill E. Clutter
Introduction
Depression
Depression is a common serious mental illness with major health, economic, and social 
consequences.  The World Health Organization (WHO) defines depression as a disorder 
characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, 
disordered sleep or appetite, decreased energy and poor concentration (1, 2).  Depressive 
feelings and symptoms can be acute or chronic, often recurrent and can considerably impair an 
individual's ability to carry out activities of daily living.  In its most extreme cases, depression 
can lead to suicide, accounting for approximately 850,000 fatalities each year (1).  The most 
common form of depression and mental disorder in the United States, Major Depressive 
Disorder (MDD), is diagnosed when an individual experiences a severely depressed mood and 
activity level that persists for two weeks or more, and affected 6.4% of the U.S. adult population 
in 2008 (3).  Criteria for classifying types of depression are established by the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) in the United States.  Depression impacts 
people of every age, sex, and ethnic background, with debilitating health care and disability 
costs.  The National Institute of Mental Health (NIMH) reports that in disability-adjusted life 
years (DALYs), depression is the leading individual disease or disorder in the US and Canada with 
an estimated 10.3 years lost due to illness, disability, and premature death, more than ischemic 
heart disease, alcohol use disorders, or pulmonary diseases (4).
Most alarming are the differences in health outcomes and health care costs for 
individuals suffering from depression and other co-morbidities.  Patients with depression have 
significantly higher mean medical costs when compared to patients without depression, in 
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every age group and category of medical care, even after adjustment for chronic medical illness. 
Patients having co-morbid depression with other chronic medical illness have shown an 
associated amplification of symptoms from physical illness, even when physiologic markers 
indicate their illness and injury are not as severe as in their non-depressed counterparts.  In 
patients with coronary heart disease and depression, there was a significant association with 
more symptomatic reports of chest pain and fatigue 5 years later.  Due to this amplification of 
symptoms, physicians are likely to order more testing on depressed patients, leading to 
increased medical costs.  In surgical inpatient populations, patients with co-morbid depressive 
illness have significantly longer lengths of stay compared with non-depressed controls, also 
contributing to increased medical costs (5).  Depression also decreases patient self-efficacy, 
increases non-adherence to recommended medical treatment, and increases mortality rates, 
especially in cardiovascular disease patients (5, 6).  Concurrent treatment of major depression 
with chronic medical illness is associated with improved health outcomes, improved functioning 
and improved quality of life (1, 5).  Given the current environment of health care debate in the 
United States, providing depression screening and effective treatment is critical to reducing 
costs while still providing the highest level of care.         
Depression can be reliably diagnosed in primary care, and adequate treatment options 
are available.  Pharmacological agents and psychotherapy are effective for 60-80% of patients, 
but fewer than 25% of those affected with depression receive treatment for their condition. 
This is due to several factors, including lack of resources, lack of trained health care providers, 
and the social stigma associated with mental disorders including depression (1, 2, 7).  In 
addition, common side effects from pharmacological treatments, including diarrhea and weight 
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gain, can counter-indicate their use for therapy and increase non-adherence, especially in at-risk 
populations (7).  Due to the significant costs, lack of availability of care, and associated social 
stigma, there is an increased need to find alternative, socially acceptable therapies for the 
treatment of depression.  
Obesity
 Like depression, obesity is significantly associated with increased risk for chronic 
diseases, such as type 2 diabetes and cardiovascular disease, and can lead to premature death 
(8, 9).  Obesity in adults is defined by the Centers for Disease Control and Prevention (CDC) as a 
body mass index (BMI) value calculated from weight and height, of 30 or higher (10).  Additional 
measures of abdominal obesity, such as waist circumference or waist-to-hip ratio can also be 
used to determine body fat distribution and obesity.  The 2007-2008 National Health and 
Nutrition Examination Survey (NHANES) estimated 34.3% of US adults age 20 or older are 
obese, with 6.0% in the obesity class III category (BMI ≥ 40) (11).  The objective from the 
Healthy People 2010 initiative by the US Department of Health and Human Services (DHHS) to 
reduce the proportion of adults who are obese was not met as obesity rates have continued to 
rise between 2000 and 2010.  Thus, a new goal of a 10% reduction in the proportion of obese 
adults was included in Healthy People 2020 (12).  Medical care costs associated with obesity 
totaled to approximately $147 billion in 2008 in the United States alone (13).  There is a 
demonstrated need for increased access to preventative medicine, improvements in health 
care, and targeted initiatives in order to begin to have a positive impact on the ongoing obesity 
epidemic.
  In addition to sharing common health complications like cardiovascular disease and 
3
diabetes, studies have shown increased risk of depression in obese populations and increased 
risk of obesity in depressed populations.  The Patient Health Questionnaire (PHQ-9) Depression 
Screener used by the  National Health and Nutrition Examination Survey (NHANES) to evaluate 
depression includes questions about the frequency of overeating, lack of sleep and physical 
activity, suggesting several possible common links between the causes of depression and 
obesity (14, 15, 16).  Ma et al. (9) found that when compared to normal weight individuals, 
obesity is associated with 2.18 times the odds of being diagnosed with major depression, with 
the highest prevalence of depression in women with class 3 obesity.  This suggests a link 
between increasing rates of obesity and increasing rates of depression.  Additionally, they found 
that women in the highest quartile of waist circumference had 2-3 times the rates of depression 
compared to women in the lowest quartile.  In a longitudinal analysis of the Northern Finland 
1966 Birth Cohort study, Herva et al. (8) found that obesity in adolescence was associated with 
depressive symptoms in adulthood among both male and female subjects.  When looking at 
abdominal obesity, they also found that abdominally obese men had a significantly higher risk 
for depressive symptoms.  Depressed women in the study who used antidepressant 
medications also demonstrated a significant increase in weight gain, which may lead to worse 
depressive symptoms (8).  Considering the higher medical costs and amplification of symptoms 
associated with depression, obesity with depression is associated with an additive additional 
risk for chronic disease, increased negative health outcomes, and higher mortality rates (5, 9, 
17).   Effective and economical treatment options for concomitant depression and obesity need 
to be explored in order to reduce overall health care costs, chronic disease rates, and improve 
health outcomes nationwide.
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Physical Activity   
One proposed method to treat both depression and obesity is through the use of 
exercise as therapy.  The overall more sedentary lifestyle in the United States may be 
contributing to increased rates of both depression and obesity, as well as their shared co-
morbidities.  Several studies have demonstrated exercise as comparable to pharmacological 
treatment and psychotherapy in treatment of depression, primarily in women (2, 6, 7, 17, 18). 
Blumenthal et al. (6) showed similar rates of depression remission in groups doing supervised 
exercise (45%), home-based exercise (40%), or taking antidepressant medication (47%), as 
compared to a pill placebo (30%) in treatment of major depressive disorder.  The only significant 
difference displayed between pharmacological treatment and exercise is the higher incidence of 
side effects, such as diarrhea, with the medication.  Additionally, exercise treatments provided 
similar results in both mildly and more severely depressed patients, indicating exercise may be 
an effective treatment for all levels of depression.  In a study comparing home-based and clinic-
based exercise interventions by Craft et al. (17), 46.9% of their total sample experienced a ≥50% 
reduction in depressive symptoms, with 31.3% of the sample achieving remission.  Exercise is 
hypothesized to increase the secretion of β-endorphins by the pituitary gland and 
hypothalamus.  These opiate-like compounds may provide an analgesic effect in the brain and 
cause general euphoria, reducing anxiety and depression levels similar to an antidepressant 
medication.  Evidence suggests that exercise-induced β-endorphin release and its effects 
depend on the type of exercise and the population tested (2).  Most notable is the fact that in all 
studies, physical activity does not carry the same social stigmas as pharmacological treatment 
or psychotherapy, and may serve as a more acceptable, affordable, and readily available 
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treatment option for depression in the general population (2, 7).
Statement of Purpose
Despite all of its benefits, there is conflicting evidence regarding whether treatment of 
depression with physical activity varies with respect to intensity, frequency, or by gender.  Dunn 
et al (7) did not show a significant difference between 3 day a week and 5 day a week exercise 
programs, but did show significantly better results in their high intensity (public health dose) 
group than in their low intensity group.  Simon et al (18) showed a significant decline in mean 
depression score over 6 months as mean physical activity score increased, but when physical 
activity declined after 6 months, mean depression scores remained stable rather than declining. 
It is unclear whether there is a threshold of intensity and regular frequency of physical activity 
that must be achieved to obtain the needed benefits from exercise to adequately treat 
depression.  In addition, a majority of studies looking at exercise as a treatment for depression 
have only looked at its effect on women, leading to questions as to whether these results are 
applicable for men.    
This investigation looks at the relationship between depression and physical activity 
based on frequency and intensity.  It also looks at the relationship between depression and 
obesity in more recent data than previous studies, to see if the relationship remains the same or 
has changed.  If a significant decline in depression scores is noted with increased levels of 
physical activity (either by frequency or intensity, or both), it may serve as a benchmark with 
which to base further trials of the effectiveness of exercise in treatment of depression.  Future 
health care treatments and preventative medicine may be adapted to reflect the increased need 
for exercise therapy in depressed and obese populations, potentially reducing health care costs 
and leading to more positive health outcomes.  Considerations also may need to be made when 
treating patients with co-morbid depression and obesity as to whether exercise may be a more 
affordable, available, and acceptable treatment option for the individual than pharmacological 
or psychotherapy treatment.      
Methods
Purpose and Objective:
The purpose of this study is to identify whether incidence or severity of depression is 
related to frequency or intensity of physical activity, or both.  It also is to identify whether there 
is a continuing trend in the relationship between depression and obesity.
Research Questions:
1. Assess the current rates and severity of depression in US adults.
2. Explore the relationship between depression and physical activity with respect to 
frequency and intensity.
3. Explore the relationship between depression and obesity.
Data Source
The data that was analyzed for this study is retrospective data obtained from the 
National Health and Nutrition Examination Survey (NHANES).  NHANES is a continuous national 
nutrition monitoring study designed to assess the health and nutritional status of adults and 
children in the United States.  It is conducted by the National Center for Health Statistics 
(NCHS), which is part of the Centers for Disease Control and Prevention (CDC).  The NHANES 
survey is unique because it combines data from both interviews and physical examinations.  The 
interview portion includes demographic, socioeconomic, dietary, and health-related questions, 
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while the physical examination includes medical, dental, physiological measurements, and 
laboratory tests, all administered by highly trained medical personnel.  
The NHANES program began in the 1960s, and was initially conducted as a series of 
surveys.  In 1999, the survey became a continuous program, where data is collected on 
approximately 5,000 Americans each year in 15 counties across the country and released in 
two-year cycles.  NHANES uses a stratified, multistage probability sample design and weighting 
methodology to produce unbiased national estimates of the civilian, non-institutionalized US 
population.  To do this, NHANES oversamples difficult to reach groups including low income 
populations, individuals who are age 60 or older, African-Americans, and Hispanics.  Interviews 
are conducted in the participants' homes, and further interviewing, health measurements and 
physical examinations are conducted in specially designed and equipped mobile examination 
centers (MEC, 19).
Subjects
We examined data from individuals aged 18 years and older in the NHANES 2007-2008 
samples.  We excluded anyone under the age of 18 and pregnant women.  For individuals to be 
included they must have completed the information in the survey regarding age, weight, height, 
body measures, depression, and physical activity (n=5392).  
Depression Screener
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The questions used in NHANES Depression Screener Questionnaire (DPQ) are taken from 
the Patient Health Questionnaire (PHQ), a version of the Prime-MD diagnostic instrument.  The 
PHQ is a self-reported assessment based on the 
nine DSM-IV signs and symptoms of depression, 
outlined in Table 1.  Each of the nine symptom 
questions is rated by the participant from "0" 
(not at all) to "3" (nearly every day).  A tenth 
follow-up question asks about how difficult 
everyday activities are to accomplish because of 
depressive symptoms.  The PHQ has been 
shown to be a reliable and valid tool for the 
diagnosis of depression.  The symptom score is 
calculated as the total of all nine items (possible score of 0-27), with a score of ≥10 indicating a 
moderate to severe level of depressive symptoms.  Further evidence-based delineation of 
depression severity is noted in Table 2 (14, 15, 16).  
Physical Activity
Physical activity data from 
NHANES provides detailed information 
about a variety of specific leisure time activities participants reported such as bicycling, walking, 
and jogging.  This data was collected in their home through a self-reported questionnaire using 
an interviewer-administered computer-assisted personal interviewing (CAPI) system (19). 
Subjects were asked questions about the activities they performed over the past 30 days.  For 
9
Total Score Depression Severity
5-9 Mild Depression
10-14 Moderate Depression
15-19 Moderately Severe Depression
Severe Depression
Table 2.  PHQ-9 Score interpretation
≥20
each activity, they collected information about the intensity (vigorous or moderate), number of 
times each, and the typical duration of activity.  These results were used to compute the 
frequency (times per week), and duration (minutes per week) of moderate, vigorous, and total 
activities.
Body Measures
The body measurement data from NHANES was collected by trained health technicians 
with a recorder.  Measured height and weight were used to calculate body mass index (BMI) by 
taking  weight in kilograms divided height in meters squared (kg/m2), rounded to the nearest 
tenth.  BMI values were used to classify individuals into weight categories as shown in Table 3. 
Waist circumference was measured in a horizontal plane around the abdomen at the level of 
the uppermost lateral border of the right ilium, with measurements recorded to the nearest 0.1 
cm (19).  A waist circumference measurement is 
considered high risk at values of >102 cm for males and 
>88 cm for females (10), which was used as the cut-off 
point to classify individuals as having abdominal obesity 
and high risk waist circumference.    
Data Analysis
To assess depression severity, we analyzed the proportion of individuals with depression 
based on established PHQ-9 depression cut-off points shown in Table 2, with moderate to 
severe depressive symptoms established at PHQ-9 scores ≥10.  A frequency analysis was used to 
determine the number of respondents with each individual symptom.  The average number of 
symptoms was determined by taking the mean (Research Question 1).  
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Classification
<18.5 Underweight
18.5-24.9 Normal Weight
25.0-29.9 Overweight
≥30 Obese
BMI (kg/m2)
Table 3. Weight classification based 
on body mass index (BMI).
Mean differences in the frequencies and durations of moderate, vigorous, and total 
physical activity were calculated.  We compared the mean differences in each category of 
physical activity by the presence or absence of moderate to severe depressive symptoms (PHQ 
≥10) using a t-test.  Statistical significance were established at p<0.05 (Research Question 2).
We assessed the relationship between obesity and depression two ways.  Using t-tests 
we compared mean BMI values by depression status (PHQ ≥10 indicating moderate to severe 
depressive symptoms), and separately compared mean waist circumference by depression 
status.  We also used a chi square analysis to compare BMI categories of weight status (as 
shown in Table 3) with existence of high risk waist circumference and depression status (PHQ 
≥10, Research Question 3).
Data was prepared and tabulated using SPSS (version 19.0, IBM SPSS Inc, Chicago, IL).  To 
account for the complex sampling design used for subject selection and the oversampling of 
target populations, data analyses were conducted using the SPSS Complex Samples module 
(version 19.0, IBM SPSS Inc, Chicago, IL).  This allows for the results to represent a nationally-
representative sample while also producing sample-based standard errors for statistical testing.
Results
We found a continuing trend that depression severity increases with obesity and higher 
BMI values.  Figure 1 below represents the mean number of depressive symptoms by BMI 
category, with the highest mean number of symptoms present for obese individuals. 
Particularly noteworthy was which depressive symptoms were reported by a higher percentage 
of obese participants: "feeling tired or having little energy" (55%), "trouble sleeping or sleeping 
too much" (43%), "poor appetite or overeating" (28%), and "little interest in doing things" 
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(26%).  The only depressive symptom which was reported more frequently by a BMI group 
other than obese was the overall rating of "difficulty these problems have caused" by 28% of 
overweight respondents versus 26% in the obese category.  Figure 2 below shows the overall 
distribution of symptoms reported by BMI category.  A higher proportion of obese individuals 
were found to have depression in all depression categories except for severe (mild, moderate, 
moderately severe, and PHQ-9 ≥10) as can be seen in Table 4 and Figure 3.  Severe depression 
was found in the same proportion in overweight and obese individuals, but still increased over 
normal weight individuals.  These findings suggest that depression is related to obesity, and that 
increasing severity of depression is also related to obesity.  Overall, 8.1% of participants were 
found to have moderate to severe depression (PHQ-9 scores ≥10) which represents about 15.9 
million Americans. 
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Figure 1: Mean Number of Depressive Symptoms
by BMI category
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Lack of physical activity appears to be related to depression as evidenced by several of 
the most common depressive symptoms which would limit the amount of physical activity 
done.  Our analysis of the physical activity data supported this relationship, as mean days and 
minutes of both moderate and vigorous recreational activities were significantly higher 
(p<0.001) in individuals without the presence of moderate to severe depression (PHQ-9 <10). 
Table 5 and Figure 4 also show 
that total minutes of physical 
activity per week were 
significantly lower in moderate to 
severe depression.  Surprisingly, 
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Figure 3: Proportion with 
Depression
By BMI category
BMI category
Overweight Obese
Depression Category Mild 15% 14% 17%
Moderate 4% 5% 7%
2% 2% 3%
Severe 0% 1% 1%
<10 94% 92% 90%
10+ 6% 8% 10%
Table 4: Proportion with 
depression by BMI category
Normal 
Weight
Moderately 
Severe
Depression Category 
(PHQ-9 score)
minutes of sedentary activity per week were found to be lower in the presence of depression, 
but the relationship was not significant (p=0.443) and the standard error was much higher (SE = 
21.4), indicating a high variability in minutes of sedentary activity reported among depressed 
individuals.  Overall, high depression status is related to both decreased frequency and 
decreased intensity of physical activity.    
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Figure 4: Mean Physical Activity 
by Depression Status  (p < 0.001)
Moderate activity (min) Vigorous activity (min) Total activity (min)
.00
10.00
20.00
30.00
40.00
50.00
60.00
Low depression score (<10) High depression score (≥10)
Total Low depression score <10
Mean SE Mean SE Mean SE P
Days moderate recreational activities 1.45 .066 1.51 .069 .76 .076 <0.001
Minutes moderate recreational activities (per day) 29.93 1.519 31.43 1.533 12.99 1.481 <0.001
Days vigorous recreational activities .83 .061 .88 .062 .28 .067 <0.001
Minutes vigorous recreational activities (per day) 20.60 1.368 21.84 1.351 6.61 1.677 <0.001
Total physical activity (minutes/day) 50.5645 2.62007 53.3146 2.59177 19.5927 2.78184 <0.001
Minutes sedentary activity (per day) 348.30 7.895 349.85 8.540 330.86 21.408 0.443
Table 5: Amount of Physical Activity by 
Depression Status
High depression score ≥10
Our comparison of mean BMI and mean percentage of waist circumference risk found a 
continuing trend of both obesity and abdominal obesity in the presence of moderate to severe 
depression.  Table 6 demonstrates that the mean BMI for depressed individuals was >30 kg/m2, 
which indicates obesity, and mean percentage of waist circumference was at 110% above the 
cutoff values for abdominal obesity.  The presence of moderate to severe depression status was 
a predictor of higher BMI and higher percentage of waist circumference risk, with all p-values 
being significant (p<0.001).      
Discussion
In this study, we hypothesized that the incidence and severity of depression is related to 
obesity.  Our results support the trend found in previous research (8, 9) that links both 
depression and severe depression to increasing rates of obesity.  Although the exact mechanism 
by which this occurs remains unknown, a potential link between the two was also found in the 
relationship to the amount of physical activity performed.  As physical activity levels are 
increased, weight can be lost, and the outlook for depression status appears to improve.
In a recently published review article by Faith et al. (20) examining prospective studies 
on the topic, they found good evidence of an obesity-to-depression relationship but did not find 
consistent evidence to adequately support the depression-to-obesity relationship.  Our results 
support this trend that obesity is associated with depression, with the possibility of a 
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Total PHQ-9 <10
Mean SE Mean SE Mean SE P
28.7 0.2 28.5 0.2 30.3 0.4 <0.001
103.7 0.5 103.1 0.5 110.2 1.0 <0.001
Table 6: BMI and Waist 
Circumference Risk by 
Depression Status
PHQ-9 ≥10
Body Mass Index (kg/m2)
Percentage of Waist 
Circumference risk
depression-to-obesity association.  Additional prospective studies exploring trends in weight 
status over time in depressed individuals may be warranted to ascertain if depression status is 
associated with reduced physical activity levels and obesity later in life.       
In the current obesigenic environment of the United States and much of the world, 
additional research is needed to explore the effectiveness of exercise and dietary interventions 
in the treatment of depression, especially in cases of co-morbid obesity.  The cultural stigma 
placed on both the obese body image and depression diagnoses also needs to be addressed so 
that individuals can feel empowered to seek treatment (20).  For depressed individuals who 
have encountered side effects from pharmacological interventions, physical activity in the 
treatment of depression may be a more acceptable and affordable option which has the 
potential to considerably decrease health care costs nationwide (7).  Obesity is a growing health 
care concern not only due to increased morbidity and mortality rates, but also because of its 
relationship to increased rates of depression and more severe depression.  With depression 
comes an even higher incidence of morbidity and mortality and higher health care costs 
associated with treatment for all conditions (3).  Proactive solutions including exercise as a 
therapy option in both conditions should be taken under serious consideration in future 
research.    
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